Publications by authors named "Gary R Cutter"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

32

Total Likes

62

Extended Reach

475,915

Social Features

47
O
Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis.
Amber Salter, Robert J Fox, Scott D Newsome, June Halper, David K B Li, Pamela Kanellis, Kathleen Costello, Bruce Bebo, Kottil Rammohan, Gary R Cutter

JAMA Neurol· June 2021

Videos about Article: user user

2 5 45 3 24

View All Article and Social Media Activity
N
Neurodevelopmental Outcomes From the PREVeNT Trial.
Sarah E O'Kelley, Jamie K Capal, Tarrant O McPherson, Kristina E Patrick, Deborah A Pearson, Gary R Cutter

Pediatr Neurol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidimensional Modeling to Maximize Adaptations to eXercise: the MAX trial rationale and study design.
Zachary A Graham, Matthew P Bubak, Christiana J Raymond-Pope, Gary R Cutter, Jeremy S McAdam

J Appl Physiol (1985)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aerobic walking exercise training boosts thalamic connectivity in MS patients with cognitive processing speed impairment.
Brian M Sandroff, Robert W Motl, Glenn R Wylie, Grace E Wells, Carly L A Wender, Gary R Cutter

Brain Cogn· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, adherence, and compliance in a RCT of supervised exercise training among persons with multiple sclerosis who have slowed cognitive processing speed.
Haley Nauman, Grace E Wells, Olesya Iosipchuk, Caroline Rafizadeh, Brendon Truax, Gary R Cutter

Mult Scler Relat Disord· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidimensional biocircuitry of exercise adaptation: integrating in vivo and ex vivo phenomics with miRNA mapping.
Jeremy S McAdam, Michael P Craig, Zachary A Graham, Brandon Peoples, S Craig Tuggle, Gary R Cutter

Physiol Genomics· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remodeling the sarcoma microenvironment by simultaneous targeting of urokinase-type plasminogen activator receptors and epidermal growth factor receptors to promote antitumor activity.
Ashley J Schulte, Mitzi Lewellen, Willa Durose, Erin Nolan, Leyla Taghizadeh, Gary R Cutter

J Pharmacol Exp Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infection, Relapses, and Pseudo-Relapses in Individuals With Multiple Sclerosis.
Amber Salter, Samantha Lancia, Mudita Sharma, Gary R Cutter, Robert J Fox

Neurol Clin Pract· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Evaluation of Two Scalability Strategies for Nationwide Dissemination of an Occupational Sun Safety Intervention in a Randomized Trial.
Richard Meenan, David B Buller, Julia Berteletti, Kimberly L Henry, Mary Klein Buller, Gary R Cutter

J Occup Environ Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlates of Processing Speed Change With Combined Cognitive Rehabilitation and Exercise in Progressive MS: Secondary Analysis of the CogEx Trial.
Brian M Sandroff, Robert W Motl, Roberto S Hernandez, Maria Pia Amato, Giampaolo Brichetto, Gary R Cutter

Neurorehabil Neural Repair· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical issues in recommending extended interval dosing.
Gary R Cutter

Mult Scler Relat Disord· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives of People With Multiple Sclerosis Regarding Data Linkage and Sharing.
Ruth Ann Marrie, Mudita Sharma, Gary R Cutter, Robert J Fox, Amber Salter

Neurology· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Composite Confirmed Disability Worsening/Progression Is a Useful Clinical Endpoint for Multiple Sclerosis Clinical Trials.
Ludwig Kappos, Sean Yiu, Frank Dahlke, Timothy Coetzee, Gary R Cutter

Neurology· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidimensional Modeling to Maximize Adaptations to eXercise: The MAX Trial Rationale and Study Design.
Zachary A Graham, Matthew P Bubak, Christiana J Raymond-Pope, Gary R Cutter, Jeremy S McAdam

medRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-acute sequela of COVID-19 infection in individuals with multiple sclerosis.
Amber Salter, Samantha Lancia, Gary R Cutter, Robert J Fox, Ruth Ann Marrie

Mult Scler· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there a threshold or dose-response association between physical activity and cognitive function in multiple sclerosis?
Brenda Jeng, Gary R Cutter, Robert W Motl

J Int Neuropsychol Soc· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of an Occupational Sun Safety Intervention: A Comparison of Two Scalability Strategies.
David B Buller, Mary Klein Buller, Richard Meenan, Gary R Cutter, Julia Berteletti

J Occup Environ Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of Simon 2-Stage Futility Trials in Early Parkinson Disease: Analysis of the PRECEPT and DATATOP Trial Datasets.
Marcus Werner Koch, Lorraine V Kalia, Justyna R Sarna, Daryl Wile, Tiago A Mestre, Gary R Cutter

Neurology· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of COVID-19 Infection on Symptom Severity and Disability in Multiple Sclerosis.
Amber Salter, Samantha Lancia, Gary R Cutter, Robert J Fox, Ruth Ann Marrie

Neurology· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlates of Inaccuracy in Reporting of Energy Intake Among Persons with Multiple Sclerosis.
Stephanie L Silveira, Brenda Jeng, Barbara A Gower, Gary R Cutter, Robert W Motl

Nutrients· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of Progression Independent of Relapse Activity as a Trial Outcome in Relapsing-Remitting Multiple Sclerosis.
Eva M M Strijbis, Jop Mostert, Jacynthe Comtois, Amber Salter, Pavle Repovic, Gary R Cutter

Neurology· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access to Care and Health-Related Quality of Life in Multiple Sclerosis.
Ruth Ann Marrie, Samantha Lancia, Gary R Cutter, Robert J Fox, Amber Salter

Neurol Clin Pract· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Pharmacodynamics of Natalizumab 6-Week Dosing vs Continued 4-Week Dosing for Relapsing-Remitting Multiple Sclerosis.
John F Foley, Gilles Defer, Lana Zhovtis Ryerson, Jeffrey A Cohen, Douglas L Arnold, Gary R Cutter

Neurol Neuroimmunol Neuroinflamm· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Preference for Subcutaneous Versus Intravenous Administration with Every-6-Week Natalizumab (Tysabri) Dosing: NOVA Phase IIIb Extension Study (Part 2).
Heinz Wiendl, John Foley, Gilles Defer, Lana Zhovtis Ryerson, Jeffrey A Cohen, Gary R Cutter

Neurol Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ketone monoester attenuates oxygen desaturation during weighted ruck exercise under acute hypoxic exposure but does not impact cognitive performance.
Tyler S McClure, Jeffrey Phillips, Dawn Kernagis, Kody Coleman, Ed Chappe, Gary R Cutter

Exp Physiol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ketone monoester attenuates declines in cognitive performance and oxygen saturation during acute severe hypoxic exposure under resting conditions.
Tyler S McClure, Jeffrey Phillips, Andrew P Koutnik, Kody Coleman, Ed Chappe, Gary R Cutter

Exp Physiol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis